The Claim
Resveratrol supplementation in older adults with Alzheimer’s disease is associated with modest improvements in cognitive test scores and neuroprotective biomarkers.
What the research says
Supports is higher
Support is ahead, but a single strong opposing study can change this.
These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.
In older adults with Alzheimer’s disease, taking resveratrol supplements is linked to small improvements in memory and thinking tests and changes in biological markers related to brain protection.
See the scientific wording
In older adults with Alzheimer’s disease, resveratrol supplementation (typically 200–500 mg/day for 12–52 weeks) is associated with modest improvements in cognitive test scores and neuroprotective biomarkers, suggesting potential neuroprotective effects, though clinical significance remains uncertain.
Resveratrol turns on a protein called SIRT1, which helps mitochondria work better and makes fewer harmful molecules that damage brain cells. This protects neurons from breakdown and keeps them communicating properly.
What the research says
1 studyStudy: Effects and safety of resveratrol supplementation in older adults: A comprehensive systematic review
This study found that older adults with Alzheimer’s who took resveratrol supplements showed small improvements in memory, which matches what the claim says. It didn’t help everyone, but it did help this group.
Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting studies
Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.